Rice Hall James & Associates’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Rice Hall James & Associates’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-101,989	Closed	-$7.68M	–	332
2015 Q2	$7.68M	Sell	101,989 -10,091	-9%	-$541K	0.44%	69
2015 Q1	$5.62M	Buy	112,080 +13,702	+14%	+$575K	0.33%	85
2014 Q4	$3.41M	Buy	98,378 +31,892	+48%	+$1.11M	0.21%	125
2014 Q3	$2.18M	Buy	66,486 +38,070	+134%	+$1.34M	0.15%	179
2014 Q2	$1.09M	Buy	28,416 +5,051	+22%	+$176K	0.07%	228
2014 Q1	$929K	Buy	+23,365	New	+$1.05M	0.07%	229

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Rice Hall James & Associates's KYTH Position: Q3 2015 in Review

Rice Hall James & Associates sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 101,989 shares — an estimated $7.68M sold.

Rice Hall James & Associates first reported a position in KYTH in Q1 2014 and held it in 6 quarters. The position peaked at $7.68M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

Rice Hall James & Associates reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
Rice Hall James & Associates sold 101,989 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $7.68M.
Rice Hall James & Associates first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 6 quarters.
Rice Hall James & Associates's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $7.68M in Q2 2015.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Rice Hall James & Associates's 13F filing for Q3 2015, filed 30 Oct 2015.